Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
gptkb:plerixafor
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:Magenta_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
MGTA-145
|
| gptkbp:indication |
stem cell transplantation
|
| gptkbp:mechanismOfAction |
CXCR2 agonist
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational drug
|
| gptkbp:target |
CXCR2 receptor
|
| gptkbp:usedFor |
hematopoietic stem cell mobilization
|
| gptkbp:bfsParent |
gptkb:Magenta_Therapeutics
|
| gptkbp:bfsLayer |
6
|